LANA NEW: Open Payments
NPI 1851939045 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,989 in 162 payments from 18 companies in 2025. Trend: 2023 $2,060 · 2024 $2,595 · 2025 $2,989
Food & beverage: $2,893Education: $97
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $662 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $443 |
| Phathom Pharmaceuticals, Inc. | 25 | $372 |
| Janssen Biotech, Inc. | 13 | $264 |
| Madrigal Pharmaceuticals | 6 | $195 |
| GENZYME CORPORATION | 12 | $186 |
| Aimmune Therapeutics, Inc. | 12 | $157 |
| Regeneron Healthcare Solutions, Inc. | 6 | $144 |
| QOL Medical, LLC | 5 | $117 |
| Lilly USA, LLC | 5 | $98 |
Products named: XIFAXAN, VOQUEZNA, DUPIXENT, TREMFYA, RINVOQ, REZDIFFRA, LINZESS, SKYRIZI.
Industry payments across KY — which companies pay providers there.
